Home › Funds › Krensavage Asset Management, LLC › ACAD

Krensavage Asset Management, LLC position in ACAD

ACADIA PHARMACEUTICALS INC · Health Care

Krensavage Asset Management, LLC reported holding 40,000 shares of ACAD (ACADIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$806K, representing 0.30% of its reported portfolio and ranking #18 among its reported holdings. Krensavage Asset Management, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)40.00K sh
Reported value held$806.00K
Portfolio Weight0.30%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's ACAD position evolved

Krensavage Asset Management, LLC first disclosed a stake in ACAD in Q3 2026 at 40,000 shares (US$806K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 40.00K $806.00K New

About ACAD and 13F data

ACAD (ACADIA PHARMACEUTICALS INC) is a Health Care company. 25 other funds we track also report a position in ACAD — the largest reported positions include BAKER BROS. ADVISORS LP (US$864.7M), RTW INVESTMENTS, LP (US$144.0M), Palo Alto Investors LP (US$50.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACAD

All ACAD fund holders →

FAQ

How long has Krensavage Asset Management, LLC held ACAD?

Krensavage Asset Management, LLC has disclosed ACAD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Krensavage Asset Management, LLC's current position in ACAD?

As of Q3 2026, Krensavage Asset Management, LLC holds 40.00K shares of ACAD (ACADIA PHARMACEUTICALS INC), valued at $806.00K, representing 0.30% of its reported portfolio and ranking #18.

Has Krensavage Asset Management, LLC been buying or selling ACAD?

In the latest 13F filing (Q3 2026), Krensavage Asset Management, LLC newly opened its position in ACAD.

Which other funds hold ACAD?

Other major institutional holders of ACAD include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Palo Alto Investors LP, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.